Sian Capital Sends Letter to OPKO Health Regarding its Decision to Apparently Withhold Rayaldee From Many Patients Amidst COVID-19’s Second Wave Believes OPKO Should Promptly Distribute FDA-Reviewed Rayaldee to Help Treat COVID-19 in the U.S. and Europe Highlights the Opportunity Being Squandered by Dr. Frost and the Board as Europe...

TUESDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against OPKO Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm LOS ANGELES, Nov. 09, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against OPKO Health, Inc. (“OPKO” or...

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against OPKO Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm LOS ANGELES, Oct. 29, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against OPKO Health, Inc. (“OPKO” or...

Barrack, Rodos & Bacine Files Securities Class Action Lawsuit Against OPKO Health, Inc. PHILADELPHIA, Sept. 14, 2018 (GLOBE NEWSWIRE) -- Barrack, Rodos & Bacine has filed a securities class action lawsuit on behalf of purchasers of the securities of OPKO Health, Inc. (NASDAQ: OPK)...